Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · February 15, 2016

Sequential vs Triple Levofloxacin Therapy in the Second-Line Treatment of Helicobacter pylori

The American Journal of Gastroenterology

 

Additional Info

The American Journal of Gastroenterology
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial
Am. J. Gastroenterol 2016 Feb 02;[EPub Ahead of Print], JM Liou, MJ Bair, CC Chen, YC Lee, MJ Chen, CC Chen, CH Tseng, YJ Fang, JY Lee, TH Yang, JC Luo, JY Wu, WH Chang, CC Chang, CY Chen, PY Chen, CT Shun, WF Hsu, HW Hung, JT Lin, CY Chang, MS Wu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading